Walgreens Boots Alliance (NASDAQ:WBA) Issues FY 2025 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 1.400-1.800 for the period, compared to the consensus estimate of 1.520. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on WBA. TD Cowen lowered their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. UBS Group lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Barclays upped their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Finally, Royal Bank of Canada reduced their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research note on Wednesday, December 4th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average target price of $12.58.

Walgreens Boots Alliance Stock Down 4.7 %

Shares of NASDAQ WBA opened at $9.22 on Friday. The company’s 50 day moving average price is $9.21 and its 200-day moving average price is $9.92. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. Walgreens Boots Alliance has a 52-week low of $8.08 and a 52-week high of $25.63. The company has a market capitalization of $7.96 billion, a P/E ratio of -0.92, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm’s revenue was up 5.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.67 EPS. Equities analysts forecast that Walgreens Boots Alliance will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.85%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.